About Nuvalent, Inc.
Nuvalent, Inc. (NUVL) has been publicly traded since 2021, making it a 5-year-old public company. It operates in the Biotechnology industry within the Healthcare sector. The company is headquartered in Cambridge, United States and employs approximately 228 people. With a market capitalization of $7.7 billion, NUVL is a mid-sized company with growth potential.
Key Statistics
- Current Price
- $98.34
- Market Cap
- $7.73B
- 52-Week High
- $113.02
- 52-Week Low
- $55.54
- Sector
- Healthcare
- Industry
- Biotechnology
$1,000 Invested
Monthly Returns Heatmap
Annual Returns
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | -2.24% | $100.59 | $98.34 |
| 2025 | +28.50% | $78.28 | $100.59 |
| 2024 | +6.37% | $73.59 | $78.28 |
| 2023 | +147.11% | $29.78 | $73.59 |
| 2022 | +56.41% | $19.04 | $29.78 |
Valuation
The forward P/E ratio is -24.6. The price-to-book ratio stands at 6.1.
Dividends
Nuvalent, Inc. does not currently pay a dividend, choosing to reinvest earnings back into the business for growth.
Risk & Volatility
NUVL has a beta of 1.32, indicating it is significantly more volatile than the overall market. The stock's 52-week range is $55.53 to $113.02, and it currently trades in the upper half of its 52-week range.
Analyst Ratings
Based on 17 analyst opinions, NUVL has a consensus "strong_buy" rating. The average price target of $143.94 suggests 47.0% upside from current levels.
Frequently Asked Questions
What does Nuvalent, Inc. do? ▼
Nuvalent, Inc. is a Biotechnology company operating in the Healthcare sector. The company is headquartered in Cambridge, United States.
What sector is NUVL in? ▼
NUVL operates in the Healthcare sector, specifically in the Biotechnology industry.
When did NUVL go public? ▼
Nuvalent, Inc. went public in 2021, making it a 5-year-old public company as of 2026.
Does NUVL pay dividends? ▼
No, Nuvalent, Inc. does not currently pay a dividend. The company reinvests its earnings into growth.
What is NUVL's market cap? ▼
Nuvalent, Inc. has a market capitalization of $7.7 billion, classifying it as a mid-cap company.
Is NUVL a buy, hold, or sell? ▼
Based on 17 opinions, NUVL has a consensus "strong_buy" rating. The average price target is $143.94.
Last updated: 3/14/2026